Medical Translation Services for Pharma, Clinical Trials & Medical Devices

Pharmaceutical content requires careful control of clinical terminology, product names, quantities, instructions and approved claims. The workflow must match the document’s purpose, intended audience, market and current source version. Regulatory product information and patient leaflets should be handled against the applicable templates and review requirements.

We agree terminology, reference materials, formatting and review responsibilities before work starts. Questions about an approved source are escalated for a documented decision, and authorized changes are propagated consistently across affected languages. Translation supports a regulatory submission; the sponsor retains responsibility for the submission strategy and required approvals.

Clinical trial translation can cover protocols, informed-consent materials, investigator and site documentation, recruitment information and participant instructions. A document written for an investigator has different language needs from one intended to help a participant understand study procedures.

Version control is essential when amendments affect several files or countries. A translation plan should distinguish new text, changed text and unchanged approved content, with review and release milestones aligned to the study. Patient-facing materials need attention to comprehension and local context as well as technical accuracy.

Instructions for use, labeling, technical documentation and device interfaces need terminology and presentation that support their intended users. The same action or component should not acquire conflicting names across the interface, quick-start instructions and full manual.

Review should address warnings, units, symbols, tables, cross-references and the final layout. ISO 13485 concerns medical-device quality management systems; it is not a translation certificate or evidence that a particular translated file has been approved. Translation requirements should be specified within the manufacturer’s applicable quality and regulatory processes.

Patient-facing medical translation should help the intended audience understand the information without changing its clinical meaning. Everyday vocabulary, sentence structure, literacy needs and cultural context deserve explicit consideration. Simplification must preserve safety information and the distinctions that matter to a patient’s decisions.

We scope linguistic and medical review to the material and audience. Where comprehension testing or readability work is needed, it should be specified as a distinct activity with defined participants, questions and documentation. It should not be assumed to have occurred simply because a translation has been proofread.

A controlled terminology resource records approved terms, context, forbidden alternatives and source references. Translation memories support reuse, but an existing segment should still be checked against the current product, audience and source version. Consistent reuse of an obsolete instruction is a quality problem.

The agreed QA plan may combine bilingual review, subject-matter review, automated checks and final-format proofreading. Automated checks can flag numbers, missing text, inconsistent terms and formatting issues; a qualified reviewer determines their significance and resolution. Review comments should produce a clear final decision rather than unresolved competing versions.

At project intake, confirm file formats, source ownership, language-country combinations, review contacts, deadlines and delivery specifications. Establish who may change the source, who reviews each language and who approves release. These responsibilities become particularly important when translation, design and clinical review run concurrently.

Technology can connect comments, versions and approvals, while project managers coordinate dependencies and resolve missing inputs. ValiTracks provides a context for discussing controlled language workflows; the team will confirm which tools and review stages fit your assignment. Confidential content should only enter an approved environment.

Send the source files and their current version, target languages and countries, intended audience, reference material, glossary and preferred delivery format. Identify whether the material concerns a clinical trial, pharmaceutical product, device or patient education, and explain any review or certification requirements.

If the assignment includes PROs or other clinical outcome assessments, identify them separately. Their translation may require licensing, a defined linguistic-validation methodology and respondent testing beyond the review needed for other study documents. We can discuss that scope with your team before estimating the work.